Dr. Irene Regan:

I thank the Deputy for her questions. I will address the capacity issue in bringing the work back to Ireland. My colleague, Dr. Lambkin, will elaborate on it further.

The Minister has referred to bringing the laboratory testing part back. Were it to return immediately, we would not have the capacity. This is a direct impact of the outsourcing. That is the unfortunate thing. Our recommendation is based on continuity of care and clinical governance in a single health system as opposed to quality standards or the metrics. We are not commenting on the latter and saying, for example, testing in the USA is inferior. Rather, we are referring to continuity of care, which we have sought for a long time. We recommend that, on its introduction, HPV testing be implemented in Ireland. My colleague will discuss HPV testing and its advantages.